|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | (2006.01) |
| A61K 9/7069 | (2013.01) | ||
| A61K 31/341 | (2006.01) | ||
| A61K 31/341 | (2013.01) | ||
| A61K 31/4468 | (2006.01) | ||
| A61K 31/00 | (2013.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 31/4468 | (2013.01) | ||
| C07D 489/08 | (2006.01) | ||
| C07D 489/08 | (2013.01) | ||
| A61K 31/485 | (2013.01) |
| (11) | Number of the document | 3197275 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15844034.7 |
| Date of filing the European patent application | 2015-09-24 | |
| (97) | Date of publication of the European application | 2017-08-02 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/051849 |
| Date | 2015-09-24 |
| (87) | Number | WO 2016/049266 |
| Date | 2016-03-31 |
| (30) | Number | Date | Country code |
| 201462054515 P | 2014-09-24 | US | |
| 201562200309 P | 2015-08-03 | US |
| (72) |
BARBIER, Remi , US
FRIEDMANN, Nadav , US
SRIRAMBHATLA, Vijay , GB
WATT, Stephen , GB
ZAMLOOT, Michael , US
|
| (73) |
Pain Therapeutics, Inc. ,
7801 N Capital of Texas Highway, Suite 260, Austin TX 78731,
US
|
| (54) | 4:3 NALTREXONE: 5-METHYL-2-FURALDEHYDE COCRYSTAL |
| 4:3 NALTREXONE: 5-METHYL-2-FURALDEHYDE COCRYSTAL |